Insider trades
Barry J. Simon, Director of ImmunityBio IBRX, has filed 0 purchases and 7 sales on the open market. Over the past 12 months that comes to a net sale of $4.1M. The latest trade was on 06/24.
Barry J. Simon
Director
- Company
- ImmunityBio IBRX
- First filing
- 23/06/09
- Trades
- 25 trades
- Buys / sales
- 0 / 7
- 12-month net buying
- −$4.1M
- Last trade
- 06/24
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
ImmunityBioIBRX | Open-market sale10b5-1 plan | 06/24 | 06/26 | 25,000 sh | $7.88 | $197,000 | −0.9% |
ImmunityBioIBRX | Open-market sale10b5-1 plan | 06/04 | 06/05 | 23,033 sh | $7.18 | $165,376.94 | −0.8% |
ImmunityBioIBRX | Open-market sale10b5-1 plan | 02/24 | 02/26 | 75,000 sh | $12.01 | $900,750 | −2.6% |
IBRX | Open-market sale10b5-1 plan | 02/20–02/23 | 02/24 | 175,000 sh2 trades | $10.19avg. | $1,783,750 | −5.6% |
IBRX | Open-market sale10b5-1 plan | 01/20 | 01/21 | 151,967 sh2 trades | $7.20avg. | $1,094,364.18 | −4.7% |